LX2931
Based on 1 Customer Validation
LX2931 is an inhibitor of Sphingosine 1-Phosphate Lyase (S1PL). LX2931 works by increasing levels of S1P inside and outside the cell. The decrease in S1PL activity leads to a significant increase in S1P content in tissues, especially in lymphoid tissues which may lead to a restricted exodus of lymphocytes from secondary immune tissues, resulting in lymphocytopenic and immunosuppressive effects in the peripheral circulation. LX2931 can be used in research for the study of autoimmune diseases, especially rheumatoid arthritis.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 98.88%
- CAS 番号: 948840-25-3
- 分子式: C9H15N3O5
- 分子量:245.23
-
保管条件:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
生物活性
化学情報
-
CAS 番号 948840-25-3
-
性状 Solid
-
分子量 245.23
-
分子式 C9H15N3O5
-
Color White to off-white
-
SMILES
OC[C@@H](O)[C@@H](O)[C@@H](C1=CN=C(/C(C)=N/O)N1)O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
溶剤 & 溶解度
DMSO : 100 mg/mL (407.78 mM; Need ultrasonic and warming; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (270 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Bagdanoff J T, et al. Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1 R, 2 S, 3 R)-1, 2, 3, 4-tetrahydroxybutyl)-1 H-imidazol-2-yl) ethanone oxime (LX2931) and (1 R, 2 S, 3 R)-1-(2-(isoxazol-3-yl)-1 H-imidazol-4-yl) butane-1, 2, 3, 4-tetraol (LX2932)[J]. Journal of medicinal chemistry, 2010, 53(24): 8650-8662. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 4.0778 mL | 20.3890 mL | 40.7780 mL | 101.9451 mL |
| 5 mM | 0.8156 mL | 4.0778 mL | 8.1556 mL | 20.3890 mL | |
| 10 mM | 0.4078 mL | 2.0389 mL | 4.0778 mL | 10.1945 mL | |
| 15 mM | 0.2719 mL | 1.3593 mL | 2.7185 mL | 6.7963 mL | |
| 20 mM | 0.2039 mL | 1.0195 mL | 2.0389 mL | 5.0973 mL | |
| 25 mM | 0.1631 mL | 0.8156 mL | 1.6311 mL | 4.0778 mL | |
| 30 mM | 0.1359 mL | 0.6796 mL | 1.3593 mL | 3.3982 mL | |
| 40 mM | 0.1019 mL | 0.5097 mL | 1.0195 mL | 2.5486 mL | |
| 50 mM | 0.0816 mL | 0.4078 mL | 0.8156 mL | 2.0389 mL | |
| 60 mM | 0.0680 mL | 0.3398 mL | 0.6796 mL | 1.6991 mL | |
| 80 mM | 0.0510 mL | 0.2549 mL | 0.5097 mL | 1.2743 mL | |
| 100 mM | 0.0408 mL | 0.2039 mL | 0.4078 mL | 1.0195 mL |